Healthy Living

Capricor's Cell Therapy Trial Shows Promising Results for Muscular Dystrophy

Present-day cell therapy

Now as the CDC cells have already shown their effectiveness in treating myocardial infarction in phase 2 and 3 studies, it means that doors have been opened for testing this therapy in heart conditions caused by other diseases that include muscular dystrophies. The success of the studies in phase 3 says that they have been proven to be safe and effective in a large number of people and the technology is practically ready to be approved by the FDA for use in clinical settings.